trial · primary record
JZP926 capsule
Juvenile Myoclonic Epilepsy
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 260 |
| Primary completion | 2028-08-01 |
| Primary endpoint | Change from baseline in myoclonic seizure days per 28 days (Part A and Part B) |
| Registry ID | NCT07723963 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:44.916Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07723963
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.